Archive for September, 2007
« Previous Entries“Good” Cholesterol Earns Its Name
Thursday, September 27th, 2007“Good” Cholesterol Earns Its Name
Study: Even When LDL “Bad” Cholesterol Is Low, High Levels Of HDL “Good” Cholesterol Help Heart
HDL cholesterol is often nicknamed “good” cholesterol, and a new study shows just how good HDL cholesterol can be for people with heart disease.
Here’s the take-home message: The higher HDL cholesterol levels were, the better, even […]
Assessment Of Fruit And Vegetable Intake’s Impact On Colon Cancer Risk
Thursday, September 27th, 2007Assessment Of Fruit And Vegetable Intake’s Impact On Colon Cancer Risk
Eating fruits and vegetables was not strongly associated with decreased colon cancer risk, according to a study published online in the Journal of the National Cancer Institute.
Several studies have examined the relationship between colon cancer and fruit and vegetable intake, but the results have […]
Roche Announces Tamiflu Will Be In Ample Supply For 2007-2008 Flu Season
Monday, September 24th, 2007Roche Announces Tamiflu Will Be In Ample Supply For 2007-2008 Flu Season
Roche announced that ample supplies of its prescription antiviral medication Tamiflu® (oseltamivir phosphate) will be widely available this flu season in pharmacies nationwide. Tamiflu is indicated for the treatment and prevention of influenza in adults and children one year and older and has been […]
More Than Eight Decades Since Its Discovery, Insulin Is Still Not Reaching Many Who Require It To Live
Monday, September 24th, 2007More Than Eight Decades Since Its Discovery, Insulin Is Still Not Reaching Many Who Require It To Live
More than 85 years since 14-year-old Leonard Thompson received the first life-saving injection and more than 65 years since the death of Frederick Banting, insulin is still not reaching many of the world’s most vulnerable citizens. No child […]
ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk Of Ischemic Cardiovascular Disease In Patients With Type 2 Diabetes
Thursday, September 20th, 2007ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk Of Ischemic Cardiovascular Disease In Patients With Type 2 Diabetes
Results presented at the 43rd Annual Meeting of the European Association for the Study of Diabetes demonstrate the ability of ACTOS(R) (pioglitazone HCl) to reduce the risk of ischemic cardiovascular disease in patients with type 2 diabetes. ACTOS is an […]
